Plexus Corp. (NASDAQ:PLXS – Get Free Report) CEO Todd Kelsey sold 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $252.77, for a total value of $379,155.00. Following the sale, the chief executive officer directly owned 72,388 shares of the company’s stock, valued at $18,297,514.76. The trade was a 2.03% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Plexus Stock Up 3.6%
Shares of Plexus stock opened at $265.72 on Friday. The stock has a market capitalization of $7.11 billion, a P/E ratio of 38.85 and a beta of 0.88. The company has a quick ratio of 0.74, a current ratio of 1.54 and a debt-to-equity ratio of 0.06. The stock has a 50 day moving average price of $230.26 and a two-hundred day moving average price of $190.15. Plexus Corp. has a 12-month low of $115.35 and a 12-month high of $275.83.
Plexus (NASDAQ:PLXS – Get Free Report) last announced its earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.18. The firm had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.13 billion. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The company’s revenue was up 18.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.66 earnings per share. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Equities analysts expect that Plexus Corp. will post 5.97 earnings per share for the current year.
Trending Headlines about Plexus
- Positive Sentiment: Zacks Research lifted its earnings estimates for Plexus across multiple future periods, including FY2026, FY2027, FY2028 and several quarterly forecasts, suggesting improved expectations for the company’s growth and profitability. This kind of estimate revision can help support the stock. Plexus earnings estimate updates
- Neutral Sentiment: A Yahoo Finance-linked article references investor reaction to Plexus accelerating ultra-secure defense hardware development with Riverside Research, which points to ongoing interest in the company’s defense-related business, but the article details provided are limited. Investor reaction article
- Negative Sentiment: Zacks Research downgraded Plexus to “Strong Sell”, which signals a bearish view despite the improved earnings estimates. Zacks downgrade
- Negative Sentiment: Plexus CEO Todd P. Kelsey sold 1,500 shares in a pre-arranged Rule 10b5-1 transaction, a move that can weigh on sentiment even though it was disclosed and routine. SEC Form 4 filing
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. Inspire Investing LLC raised its stake in shares of Plexus by 1.6% in the fourth quarter. Inspire Investing LLC now owns 3,178 shares of the technology company’s stock valued at $467,000 after purchasing an additional 50 shares in the last quarter. Allworth Financial LP raised its stake in Plexus by 20.8% during the fourth quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock worth $44,000 after acquiring an additional 52 shares in the last quarter. Maryland State Retirement & Pension System raised its stake in Plexus by 1.5% during the fourth quarter. Maryland State Retirement & Pension System now owns 3,940 shares of the technology company’s stock worth $579,000 after acquiring an additional 60 shares in the last quarter. Oregon Public Employees Retirement Fund raised its stake in Plexus by 1.2% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,175 shares of the technology company’s stock worth $908,000 after acquiring an additional 71 shares in the last quarter. Finally, Uncommon Cents Investing LLC raised its stake in Plexus by 0.8% during the fourth quarter. Uncommon Cents Investing LLC now owns 9,925 shares of the technology company’s stock worth $1,459,000 after acquiring an additional 75 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research firms have recently weighed in on PLXS. Raymond James Financial reissued an “outperform” rating and issued a $275.00 price objective on shares of Plexus in a research report on Thursday, April 30th. Needham & Company LLC increased their price objective on Plexus from $206.00 to $285.00 and gave the company a “buy” rating in a research report on Friday, May 1st. Zacks Research cut Plexus from a “hold” rating to a “strong sell” rating in a research report on Wednesday. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Weiss Ratings raised Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, May 11th. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Plexus has an average rating of “Moderate Buy” and a consensus target price of $229.17.
Get Our Latest Analysis on PLXS
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Plexus
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
- MarketBeat Week in Review – 05/18 – 05/22
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
